• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015-2016 season and comparison of HA mutations detected in Turkey

tetano

Editor, Senior Moderator
J Med Virol. 2019 Aug 7. doi: 10.1002/jmv.25565. [Epub ahead of print]
[h=1]Molecular characterization of the influenza A(H1N1)pdm09 isolates collected in the 2015-2016 season and comparison of HA mutations detected in Turkey since 2009.[/h] Guldemir D[SUP]1[/SUP], Coskun-Ari FF[SUP]1[/SUP], Altas AB[SUP]2[/SUP], Bakkaloglu Z[SUP]1[/SUP], Unaldi O[SUP]1[/SUP], Bayraktar F[SUP]2[/SUP], Korukluoglu G[SUP]2[/SUP], Aktas AR[SUP]1[/SUP], Durmaz R[SUP]3[/SUP].
[h=3]Author information[/h] 1 National Molecular Microbiology Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Turkey. 2 National Viral Respiratory Pathogens Reference Laboratory, Public Health General Directorate, Ministry of Health, Ankara, Turkey. 3 Department of Clinical Microbiology, Faculty of Medicine, Yildirim Beyazit University, Ankara, Turkey.

[h=3]Abstract[/h] Influenza A(H1N1)pdm09 pandemic virus causing the 2009 global outbreak moved into the post-pandemic period, but its variants continued to be the prevailing subtype in the 2015-2016 influenza season in Europe and Asia. To determine the molecular characteristics of influenza A(H1N1)pdm09 isolates circulating during the 2015-2016 season in Turkey, we identified mutations in the hemagglutinin (HA) genes and investigated the presence of H275Y alteration in the neuraminidase (NA) genes in the randomly selected isolates. The comparison of the HA nucleotide sequences revealed a very high homology (>99,5%) among the studied influenza A(H1N1)pdm09 isolates, while a relatively low homology (96,6%-97,2%) was observed between Turkish isolates and the A/California/07/2009 vaccine virus. Over all 14 common mutations were detected in HA sequences of all 2015-2016 influenza A(H1N1)pdm09 isolates with respect to the A/California/07/2009 virus, four of which located in three different antigenic sites. Eleven rare mutations in twelve HA sequences were also detected. Phylogenetic analysis revealed that all characterized influenza A(H1N1)pdm09 isolates formed a single genetic cluster, belonging to the genetic subclade 6B.1, defined by HA amino acid substitutions S84N, S162N, and I216T. Furthermore, all isolates showed an oseltamivir-sensitive genotype, suggesting that Tamiflu[SUP]?[/SUP] (Oseltamivir) could still be the drug of choice in Turkey. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.


[h=4]KEYWORDS:[/h] 2015-2016 influenza season; HA; Influenza A(H1N1)pdm09; NA; Oseltamivir resistance

PMID: 31389035 DOI: 10.1002/jmv.25565
 
Back
Top